Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Astech Projects Comes of Age at 18 Years Old

Published: Wednesday, July 10, 2013
Last Updated: Wednesday, July 10, 2013
Bookmark and Share
Astech celebrates milestone by offering free consultations and proposal of their turnkey approach to automation.

Astech was started with the founders’ vision to be “recognised as one of the world’s best” in the design and supply of custom robotics and automation for use in advanced manufacturing industries including pharmaceutical, medical device, consumer healthcare, petro-chemical and chemical. This has largely been achieved by providing the very best automation solutions tailored to customer’s unique and individual requirements.

Having gone from strength to strength with an increasing sized workforce, two relocations to larger premises and a Queen’s Award for Enterprise: Innovation, Astech Director, Anthony Moran commented “This is a significant milestone for us and we hope it reinforces our reputation for quality and longevity. We have ambitious plans to broaden our product portfolio and to keep offering valuable solutions to our customers”. He continued: "We are committed to being ‘best in class’ and if we continue to improve we can only become even more successful.  In addition to thanking our dedicated Astech team for all their hard work and commitment over the last 18 years we would like to thank our many clients that have entrusted Astech to provide them with innovative and intelligent design solutions”
To celebrate their anniversary Astech are currently offering a free consultation and proposal of their novel turnkey approach to automation which can consist of four key steps: (1) consultation & proposal, (2) concept design study, (3) proof of concept(s) and (4) detailed design, manufacture and testing. Simply complete the online form and one of Astech’s specialist Business Development Mangers will contact you.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos